Company / Capital Expenditures
Praxis Precision Medicines, Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$56.0K
FY2025
5-year range
$0 / $1.1M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#176 of 194
Health Care
What the data says
Among 194 Health Care companies, Praxis Precision Medicines, Inc. is in the bottom 9% for capital expenditures. Capital Expenditures returned to growth in FY2025 after 3 years of decline, reaching $56,000.
Based on SEC 10-K filings.
$56,000 in FY2025 with a 3-year CAGR of -49.9%.
Improved from $50,000 to $56,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -49.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 194This company $56.0K Sector average $117.5M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -49.9%, indicating a declining trend.
- Ranks #176 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $50.0K | -88.7% |
| FY2022 | $444.0K | -57.7% |
| FY2021 | $1.1M | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $103.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026